R&D Investment Overview - In 2024, U.S. companies invested $675 billion in R&D, accounting for 52% of global investment, while Chinese companies invested $165 billion, representing 13% of the total[3] - Over the past decade, China has rapidly closed the gap, with four out of nine advanced industries now seeing higher R&D investments from Chinese firms compared to U.S. firms[3] Cost and Efficiency - China's R&D costs are approximately 20% lower than those in the U.S. when adjusted for wages[5] - Excluding software and biopharmaceuticals, Chinese companies' R&D investments in seven advanced industries have surpassed those of U.S. companies by 6%[6] Legislative Recommendations - To maintain competitiveness in advanced industries, Congress should triple funding for industry-academic research collaborations and increase simplified R&D tax credits from 14% to at least 28%[7] Global R&D Trends - The global R&D investment growth from 2014 to 2024 was 102%, with U.S. investments increasing by 150% and Chinese investments soaring by 537%[13] - The concentration of global R&D is shifting towards a binary world dominated by U.S. and Chinese firms, leaving other regions stagnant[4] Sector-Specific Insights - In the pharmaceutical and biotechnology sector, U.S. companies lead with 181 firms, while China has 149 firms in the electronics and electrical equipment sector[15] - By 2024, U.S. companies' share of global R&D in the automotive sector is projected to be 19%, while Chinese firms will account for 15%[82] Adjusted Investment Metrics - When controlling for GDP, U.S. companies invested $15.41 per $1,000 GDP in R&D, while Chinese companies increased their investment from $5.59 to $23.48 per $1,000 GDP from 2014 to 2024[20][24] - The location quotient (LQ) for Chinese companies in advanced industries rose from 0.7 to 1.5, while U.S. companies' LQ decreased from 1.8 to 1.7[12][42]